154 related articles for article (PubMed ID: 24080659)
1. BMS-986001, an HIV nucleoside reverse transcriptase inhibitor, does not degrade mitochondrial DNA in long-term primary cultures of cells isolated from human kidney, muscle, and adipose tissue.
Wang F; Flint OP
Antimicrob Agents Chemother; 2013 Dec; 57(12):6205-12. PubMed ID: 24080659
[TBL] [Abstract][Full Text] [Related]
2. Assessment of mitochondrial toxicity in human cells treated with tenofovir: comparison with other nucleoside reverse transcriptase inhibitors.
Birkus G; Hitchcock MJ; Cihlar T
Antimicrob Agents Chemother; 2002 Mar; 46(3):716-23. PubMed ID: 11850253
[TBL] [Abstract][Full Text] [Related]
3. Tenofovir exhibits low cytotoxicity in various human cell types: comparison with other nucleoside reverse transcriptase inhibitors.
Cihlar T; Birkus G; Greenwalt DE; Hitchcock MJ
Antiviral Res; 2002 Apr; 54(1):37-45. PubMed ID: 11888656
[TBL] [Abstract][Full Text] [Related]
4. The HIV-1 nucleoside reverse transcriptase inhibitors stavudine and zidovudine alter adipocyte functions in vitro.
Caron M; Auclair M; Lagathu C; Lombès A; Walker UA; Kornprobst M; Capeau J
AIDS; 2004 Nov; 18(16):2127-36. PubMed ID: 15577645
[TBL] [Abstract][Full Text] [Related]
5. In vitro cytotoxicity and mitochondrial toxicity of tenofovir alone and in combination with other antiretrovirals in human renal proximal tubule cells.
Vidal F; Domingo JC; Guallar J; Saumoy M; Cordobilla B; Sánchez de la Rosa R; Giralt M; Alvarez ML; López-Dupla M; Torres F; Villarroya F; Cihlar T; Domingo P
Antimicrob Agents Chemother; 2006 Nov; 50(11):3824-32. PubMed ID: 16940060
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial tubulopathy in tenofovir disoproxil fumarate-treated rats.
Lebrecht D; Venhoff AC; Kirschner J; Wiech T; Venhoff N; Walker UA
J Acquir Immune Defic Syndr; 2009 Jul; 51(3):258-63. PubMed ID: 19582894
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial toxicity of tenofovir, emtricitabine and abacavir alone and in combination with additional nucleoside reverse transcriptase inhibitors.
Venhoff N; Setzer B; Melkaoui K; Walker UA
Antivir Ther; 2007; 12(7):1075-85. PubMed ID: 18018766
[TBL] [Abstract][Full Text] [Related]
8. In vitro and ex vivo inhibition of human telomerase by anti-HIV nucleoside reverse transcriptase inhibitors (NRTIs) but not by non-NRTIs.
Hukezalie KR; Thumati NR; Côté HC; Wong JM
PLoS One; 2012; 7(11):e47505. PubMed ID: 23166583
[TBL] [Abstract][Full Text] [Related]
9. Tenofovir renal proximal tubular toxicity is regulated by OAT1 and MRP4 transporters.
Kohler JJ; Hosseini SH; Green E; Abuin A; Ludaway T; Russ R; Santoianni R; Lewis W
Lab Invest; 2011 Jun; 91(6):852-8. PubMed ID: 21403643
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms of tenofovir resistance conferred by human immunodeficiency virus type 1 reverse transcriptase containing a diserine insertion after residue 69 and multiple thymidine analog-associated mutations.
White KL; Chen JM; Margot NA; Wrin T; Petropoulos CJ; Naeger LK; Swaminathan S; Miller MD
Antimicrob Agents Chemother; 2004 Mar; 48(3):992-1003. PubMed ID: 14982794
[TBL] [Abstract][Full Text] [Related]
11. Subcellular renal proximal tubular mitochondrial toxicity with tenofovir treatment.
Kohler JJ; Hosseini SH
Methods Mol Biol; 2011; 755():267-77. PubMed ID: 21761311
[TBL] [Abstract][Full Text] [Related]
12. From old to new nucleoside reverse transcriptase inhibitors: changes in body fat composition, metabolic parameters and mitochondrial toxicity after the switch from thymidine analogs to tenofovir or abacavir.
Curran A; Ribera E
Expert Opin Drug Saf; 2011 May; 10(3):389-406. PubMed ID: 21235431
[TBL] [Abstract][Full Text] [Related]
13. The early effects of stavudine compared with tenofovir on adipocyte gene expression, mitochondrial DNA copy number and metabolic parameters in South African HIV-infected patients: a randomized trial.
Menezes CN; Duarte R; Dickens C; Dix-Peek T; Van Amsterdam D; John MA; Ive P; Maskew M; Macphail P; Fox MP; Raal F; Sanne I; Crowther NJ
HIV Med; 2013 Apr; 14(4):217-25. PubMed ID: 23036096
[TBL] [Abstract][Full Text] [Related]
14. Impact of nucleoside reverse transcriptase inhibitors on mitochondrial DNA and RNA in human skeletal muscle cells.
Saitoh A; Haas RH; Naviaux RK; Salva NG; Wong JK; Spector SA
Antimicrob Agents Chemother; 2008 Aug; 52(8):2825-30. PubMed ID: 18541728
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial function, inflammation, fat and bone in HIV lipoatrophy: randomized study of uridine supplementation or switch to tenofovir.
McComsey GA; O'Riordan M; Choi J; Libutti D; Rowe D; Storer N; Harrill D; Gerschenson M
Antivir Ther; 2012; 17(2):347-53. PubMed ID: 22293126
[TBL] [Abstract][Full Text] [Related]
16. [Tenofovir as a strategy to avoid or limit adverse effects].
Portilla J
Enferm Infecc Microbiol Clin; 2008 Jun; 26 Suppl 8():19-24. PubMed ID: 19195434
[TBL] [Abstract][Full Text] [Related]
17. Adefovir nephrotoxicity: possible role of mitochondrial DNA depletion.
Tanji N; Tanji K; Kambham N; Markowitz GS; Bell A; D'agati VD
Hum Pathol; 2001 Jul; 32(7):734-40. PubMed ID: 11486172
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D attenuates nucleoside reverse transcriptase inhibitor induced human skeletal muscle mitochondria DNA depletion.
Campbell GR; Pallack ZT; Spector SA
AIDS; 2013 Jun; 27(9):1397-401. PubMed ID: 23435299
[TBL] [Abstract][Full Text] [Related]
19. Relationship of mitochondrial DNA depletion and respiratory chain activity in preadipocytes treated with nucleoside reverse transcriptase inhibitors.
Stankov MV; Lücke T; Das AM; Schmidt RE; Behrens GM;
Antivir Ther; 2007; 12(2):205-16. PubMed ID: 17503663
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of mitochondrial DNA content and enzyme levels in tenofovir DF-treated rats, rhesus monkeys and woodchucks.
Biesecker G; Karimi S; Desjardins J; Meyer D; Abbott B; Bendele R; Richardson F
Antiviral Res; 2003 May; 58(3):217-25. PubMed ID: 12767469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
